NCT00117676 - A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B | Biotech Hunter

Enrollment

382

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

January 31, 2016

Conditions

Chronic Hepatitis B

Interventions

DRUG

TDF

300 mg tablet administered orally once daily

DRUG

ADV

10 mg tablet administered orally once daily

DRUG

TDF placebo

Tablet administered orally once daily

DRUG

ADV placebo

Tablet administered orally once daily

DRUG

FTC/TDF

200/300 mg fixed-dose combination (FDC) tablet administered orally once daily

Trial Locations (80)

1407

Sofia

1431

Sofia

2050

Camperdown

2139

Concord

2145

Westmead

3004

Prahan

3015

Rotterdam

3065

Fitzroy

3084

Heidelberg

3168

Clayton

9010

Varna

10003

New York

10029

New York

10134

Torino

11355

Flushing

11526

Athens

14021

Prague

20099

Hamburg

22042

Falls Church

23298

Richmond

28222

Majadahonda

30308

Atlanta

30623

Hanover

31059

Toulouse

34098

Istanbul

34899

Istanbul

40102

Woolloongabba

40138

Bologna

40237

Düsseldorf

41110

Larissa

44623

Herne

46009

Valencia

48109

Ann Arbor

48202

Detroit

54500

Nancy

54636

Thessaloniki

55131

Mainz

56429

Thessaloniki

57010

Thessaloniki

59037

Lille

60590

Frankfurt

62500

Brno

63104

St Louis

66421

Homburg/Saar

67901

Strasbourg

69317

Lyon

72076

Tübingen

75651

Paris

81377

München

91105

Pasadena

92037

La Jolla

92105

San Diego

92110

Clichy

92123

San Diego

94010

Créteil

94115

San Francisco

95116

San Jose

96817

Honolulu

02215

Boston

T2N 4Z6

Calgary

V5Z1H2

Vancouver

R3E3P4

Winnipeg

M5T 2S8

Toronto

Unknown

Hradec Králové

Auckland

Hamilton

Whakatane

Bursa

Izmir

169 02

Praha 6 - Stresovice

04103

Leipzig

15-540

Bialystok

85-030

Bydgoszcz

41-500

Chorzów

31-501

Krakow

01-201

Warsaw

50-136

Wroclaw

08035

Barcelona

NW1 2BU

London

WC1E 6HX

London